Xu X - Search Results

1

Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI.

Tang Y, Xia B, Xie R, Xu X, Zhang M, Wu K, Wang B, Ma S. Tang Y, et al. Among authors: xu x. Lung Cancer. 2020 Feb;140:65-70. doi: 10.1016/j.lungcan.2019.12.009. Epub 2019 Dec 18. Lung Cancer. 2020. PMID: 31884128

2

Parallel phase 1 clinical trials in the US and in China: accelerating the test of avitinib in lung cancer as a novel inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance.

Xu X. Xu X. Chin J Cancer. 2015 Jul 8;34(7):285-7. doi: 10.1186/s40880-015-0029-3. Chin J Cancer. 2015. PMID: 26152224 Free PMC article. Clinical Trial.

3

Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.

Zhu L, Zhang S, Xu X, Wang B, Wu K, Deng Q, Xia B, Ma S. Zhu L, et al. Among authors: xu x. PLoS One. 2016 May 26;11(5):e0156494. doi: 10.1371/journal.pone.0156494. eCollection 2016. PLoS One. 2016. PMID: 27227819 Free PMC article. Review.

4

AC0010, an Irreversible EGFR Inhibitor Selectively Targeting Mutated EGFR and Overcoming T790M-Induced Resistance in Animal Models and Lung Cancer Patients.

Xu X, Mao L, Xu W, Tang W, Zhang X, Xi B, Xu R, Fang X, Liu J, Fang C, Zhao L, Wang X, Jiang J, Hu P, Zhao H, Zhang L. Xu X, et al. Among authors: xu r, xu w. Mol Cancer Ther. 2016 Nov;15(11):2586-2597. doi: 10.1158/1535-7163.MCT-16-0281. Epub 2016 Aug 29. Mol Cancer Ther. 2016. PMID: 27573423

5

First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance.

Ma Y, Zheng X, Zhao H, Fang W, Zhang Y, Ge J, Wang L, Wang W, Jiang J, Chuai S, Zhang Z, Xu W, Xu X, Hu P, Zhang L. Ma Y, et al. Among authors: xu w, xu x. J Thorac Oncol. 2018 Jul;13(7):968-977. doi: 10.1016/j.jtho.2018.03.025. Epub 2018 Apr 4. J Thorac Oncol. 2018. PMID: 29626621 Free article. Clinical Trial.

6

Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy.

Wu K, Xu X, Li X, Wang J, Zhu L, Chen X, Wang B, Zhang M, Xia B, Ma S. Wu K, et al. Among authors: xu x. J Thorac Dis. 2018 Dec;10(12):6531-6539. doi: 10.21037/jtd.2018.11.132. J Thorac Dis. 2018. PMID: 30746197 Free PMC article.

7

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial.

Zhang YC, Chen ZH, Zhang XC, Xu CR, Yan HH, Xie Z, Chuai SK, Ye JY, Han-Zhang H, Zhang Z, Bai XY, Su J, Gan B, Yang JJ, Li WF, Tang W, Luo FR, Xu X, Wu YL, Zhou Q. Zhang YC, et al. Among authors: xu cr, xu x. EBioMedicine. 2019 May;43:180-187. doi: 10.1016/j.ebiom.2019.04.030. Epub 2019 Apr 23. EBioMedicine. 2019. PMID: 31027916 Free PMC article.

8

A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.

Wu K, Zhu L, Wang J, Pan K, Wang B, Li X, Yang S, Xu X, Zhang M, Li X, Chen X, Ma S, Xia B. Wu K, et al. Among authors: xu x. J Thorac Dis. 2019 Nov;11(11):4529-4537. doi: 10.21037/jtd.2019.10.81. J Thorac Dis. 2019. PMID: 31903241 Free PMC article.

9

Erratum to "Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI" [Lung Cancer, 140 (February) (2020) 65-70].

Tang Y, Xia B, Xie R, Xu X, Zhang M, Wu K, Wang B, Ma S. Tang Y, et al. Among authors: xu x. Lung Cancer. 2020 Apr;142:142. doi: 10.1016/j.lungcan.2020.01.016. Epub 2020 Feb 27. Lung Cancer. 2020. PMID: 32115256 No abstract available.

10

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II Study.

Zhou Q, Wu L, Hu P, An T, Zhou J, Zhang L, Liu XQ, Luo F, Zheng X, Cheng Y, Yang N, Li J, Feng J, Han B, Song Y, Wang K, Zhang L, Fang J, Zhao H, Shu Y, Lin XY, Chen Z, Gan B, Xu WH, Tang W, Zhang X, Yang JJ, Xu X, Wu YL. Zhou Q, et al. Among authors: xu wh, xu x. Clin Cancer Res. 2022 Mar 15;28(6):1127-1135. doi: 10.1158/1078-0432.CCR-21-2595. Clin Cancer Res. 2022. PMID: 34740925 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,529 results

Search Page

Filters